Evolving role of Sorafenib in the management of hepatocellular carcinoma

doi:10.5306/wjco.v8.i3.203

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (11539)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series.

Item

Count

PDF

1027

WORD

456

HTML

6830

Figures (1-2)

265

Sum=8578

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1229

Download

1732

Sum=2961

Jun 10, 2017 (publication date) through Nov 25, 2024

Times Cited of This Article

Times Cited (29)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Clin Oncol. Jun 10, 2017; 8(3): 203-213
Published online Jun 10, 2017. doi: 10.5306/wjco.v8.i3.203

Full Size Figure Download Figure

Figure 2 Barcelona clinic liver cancer staging system and treatment algorithm. PS: Performance status; N: Nodules; M: Metastases; HCC: Hepatocellular carcinoma.

Citation: Ziogas IA, Tsoulfas G. Evolving role of Sorafenib in the management of hepatocellular carcinoma. World J Clin Oncol 2017; 8(3): 203-213
URL: https://www.wjgnet.com/2218-4333/full/v8/i3/203.htm
DOI: https://dx.doi.org/10.5306/wjco.v8.i3.203